AlphAIalphai — Financial news for AI agents
yahoo.comAUG 76 min read$DKL

Delek Logistics Partners, LP Q2 2026 Earnings Call Summary

Delek Logistics Partners (DKL) reported record Q2 2026 adjusted EBITDA of $144 million, citing higher Delaware crude volumes and improved Libby gas utilization. It reaffirmed full-year 2026 adjusted EBITDA guidance of $520 million to $560 million, announced a $1.135 per-unit distribution, issued $800 million senior notes, and discussed growth from sour gas and produced-water services.

Original reporting
yahoo.com
Published Aug 7, 2026, 1:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 1:07 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Delek Logistics Partners, LP Q2 2026 Earnings Call Summary — source image
Source · yahoo.com
Decision brief

The 30-second read

$DKLBullishMed
01

Why it matters

Traders can update expectations for 2026 EBITDA and 2027 run-rate based on reaffirmed guidance, a stated utilization step-change from sour-gas infrastructure, and a refinancing that extends maturities to 2034.

02

Market read

Record volumes, reaffirmed 2026 EBITDA guidance, and a specific $800M refinancing are the main catalysts, with sour-gas and produced-water projects as the growth engine.

03

What to watch

Wholesale Marketing and Terminalling EBITDA declined due to the 2024 amend-and-extend agreement with Delek US, which could cap total segment earnings even if gathering volumes rise.

Relevance 8/10Novelty 7/10Timing: earnings call summary published pre-market today

Background

The piece summarizes Delek Logistics Partners, LP’s Q2 2026 earnings call, focusing on operating drivers, guidance, capital allocation, and leverage.

Company-level read

Ticker impact

$DKLBullishMedium confidence
Context

Delek Logistics Partners reported record Q2 adjusted EBITDA, reaffirmed 2026 guidance, and issued $800M senior notes to 2034, shaping near-term leverage and cash-flow expectations.

Expected impact

Moderately positive bias for DKL as traders price improved financing terms and higher 2026-2027 run-rate EBITDA from sour-gas and produced-water projects.

Evidence & confidence

The article discloses multiple concrete, decision-relevant items: record EBITDA drivers, explicit 2026 EBITDA range, a specific $800M notes issuance, and a stated leverage target path back toward 3.5x.

Market effects

Sector

Reinforces Permian midstream demand for sour-gas gathering and produced-water handling, potentially supporting sentiment for other Delaware/Midland operators.

Regional

Highlights Northern Delaware Basin activity and Waha-driven volume growth, which can influence regional midstream utilization expectations.

Global

Limited direct global linkage; primarily a North American natural gas and crude midstream utilization story.

Counterpoint

What could challenge this read

The leverage ratio rose to 4.23x due to front-loaded capex, so the market may discount near-term free cash flow until the utilization step-change fully materializes.

Key entities

  • issuer
    Delek Logistics Partners, LP

    Permian-focused midstream partnership reporting record adjusted EBITDA, reaffirming 2026 guidance, and issuing $800M senior notes to 2034.

  • sponsor/related party
    Delek US

    Sponsor referenced for economic separation and for a 2024 amend-and-extend agreement impacting Wholesale Marketing and Terminalling EBITDA.

Read at source← All news

Related articles

AUG 5
$DKLMed

Delek Logistics Partners, LP (DKL): Results of Operations and Financial Condition

Delek Logistics Partners, LP (DKL) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 dkl-ex991xearningsreleasex.htm EX-99.1 Document Exhibit 99.1 Delek Logistics Reports Second Quarter 2026 Results • Delek Logistics reported net income of $28.9 million or $0.54 per unit, and adjusted EBITDA of $143.5 million • Nearing completion of the integrated sour g

SEC EDGAR 8-K4 min
MAY 27
$CVXMed

3 Energy Stocks Built to Last a Lifetime and Pay You the Whole Way

The article highlights energy stocks with higher dividend yields than the S&P 500’s ~1.1%. It cites the S&P Energy Select Sector index yield of 2.7% and notes 69 U.S.-listed energy stocks yield at least 3%. It spotlights Chevron (3.78% yield; 39 straight dividend increases; Q1 shareholder rewards $6B), Delek Logistics (8.76% yield; April payout increase; 23.7% YoY earnings growth; plans to source 80% of 2026 EBITDA from third parties), and Kinetik (6.3% yield; reiterated 2026 EBITDA guidance; bu

fool.com7 min
MAY 27
$CVXMed

3 Energy Stocks Built to Last a Lifetime and Pay You the Whole Way

The article highlights energy as an S&P 500 sector with higher dividend yields, citing a 2.7% yield for the S&P Energy Select Sector index. It spotlights Chevron (3.7% yield; 39 straight dividend increases; Q1 shareholder rewards $6B), Delek Logistics (8.8% yield; April payout increase; 23.7% YoY earnings growth; expects 80% of 2026 EBITDA from third parties), and Kinetik (6.3% yield; reiterated 2026 EBITDA guidance).

finance.yahoo.com7 min
AUG 7
$CVNAMedAI 8/10

Former penny stock nearing bankruptcy reports record profit

Carvana (CVNA) reported record Q2 2026 results, including revenue of $7.4 billion, net income of $513 million, and operating income of $680 million, with adjusted EBITDA reaching a $3 billion annual run rate. The company cited a turnaround in balance sheet and cash flow. Analysts cited mixed reactions, with Barclays and Wells Fargo cutting targets while Needham reiterated Buy.

yahoo.com6 min
AUG 7
$DAVEMedAI 8/10

Dave Q2 Earnings Call Highlights

Dave Inc. (NASDAQ:DAVE) reported Q2 metrics and discussed pricing changes, ExtraCash limit increases, and rolling out CashAI v6 to about one-third of users. Non-GAAP gross profit rose 34% to $124M, and 28-day past-due improved to 2.12%. Provision for credit losses was $29M. Dave raised 2026 guidance: revenue $725M-$735M, adj. EBITDA $315M-$325M, adj. diluted EPS $17.00-$17.50.

yahoo.com6 min
AUG 7
$XBIOMed

Xenetic Biosciences, Inc.: Xenetic Biosciences Reports Second Quarter 2026 Financial Results and Highlights Strengthened Scientific Foundation Supporting Continued Advancement of Proprietary DNase Pla

Xenetic Biosciences (NASDAQ:XBIO) reported Q2 2026 results for the quarter ended June 30. Royalty revenue rose about 12% to about $0.7M, while R&D fell about 16% to about $0.6M. G&A increased about 64% to about $1.1M, driving a net loss of about $0.9M. Cash was about $6.5M. The company cited ASCO preclinical/translational data and a PeriNess study approval.

finanznachrichten.de4 min